Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Aktuální cena Merck & Co Inc na trhu je 3 140,71 Kč s 24hodinovým objemem obchodování 0 Kč. Tržní kapitalizace aktiva je 7,74T Kč po změně o -1.32% za poslední den.
Tokenizovaný Merck & Co Inc se obchoduje za 3 161,26 Kč, s tokenizovanou tržní kapitalizací 7,41M Kč a 24hodinovým objemem obchodování 18,75M Kč. Tokenizované aktivum se posunulo o -6.62% za posledních 24 hodin.